170 related articles for article (PubMed ID: 20145093)
21. Intracellular trafficking of Clostridium botulinum C2 toxin.
Nagahama M; Takahashi C; Aoyanagi K; Tashiro R; Kobayashi K; Sakaguchi Y; Ishidoh K; Sakurai J
Toxicon; 2014 May; 82():76-82. PubMed ID: 24582943
[TBL] [Abstract][Full Text] [Related]
22. The actin-ADP-ribosylating Clostridium botulinum C2 toxin.
Aktories K; Barth H
Anaerobe; 2004 Apr; 10(2):101-5. PubMed ID: 16701506
[TBL] [Abstract][Full Text] [Related]
23. The Pore-Forming Subunit C2IIa of the Binary
Eisele J; Schreiner S; Borho J; Fischer S; Heber S; Endres S; Fellermann M; Wohlgemuth L; Huber-Lang M; Fois G; Fauler M; Frick M; Barth H
Front Pharmacol; 2022; 13():810611. PubMed ID: 35222028
[TBL] [Abstract][Full Text] [Related]
24. Clostridial actin-ADP-ribosylating toxins.
Aktories K; Wille M; Just I
Curr Top Microbiol Immunol; 1992; 175():97-113. PubMed ID: 1628500
[No Abstract] [Full Text] [Related]
25. Combined Pharmacological Inhibition of Cyclophilins, FK506-Binding Proteins, Hsp90, and Hsp70 Protects Cells From
Ernst K; Kling C; Landenberger M; Barth H
Front Pharmacol; 2018; 9():1287. PubMed ID: 30483129
[TBL] [Abstract][Full Text] [Related]
26. Cross-reactivity of anthrax and C2 toxin: protective antigen promotes the uptake of botulinum C2I toxin into human endothelial cells.
Kronhardt A; Rolando M; Beitzinger C; Stefani C; Leuber M; Flatau G; Popoff MR; Benz R; Lemichez E
PLoS One; 2011; 6(8):e23133. PubMed ID: 21850257
[TBL] [Abstract][Full Text] [Related]
27. Receptor-Binding and Uptake of Binary Actin-ADP-Ribosylating Toxins.
Papatheodorou P; Aktories K
Curr Top Microbiol Immunol; 2017; 406():119-133. PubMed ID: 27817176
[TBL] [Abstract][Full Text] [Related]
28. Clostridium botulinum C2 toxin. Identification of the binding site for chloroquine and related compounds and influence of the binding site on properties of the C2II channel.
Neumeyer T; Schiffler B; Maier E; Lang AE; Aktories K; Benz R
J Biol Chem; 2008 Feb; 283(7):3904-14. PubMed ID: 18077455
[TBL] [Abstract][Full Text] [Related]
29. Cyclophilin A facilitates translocation of the Clostridium botulinum C2 toxin across membranes of acidified endosomes into the cytosol of mammalian cells.
Kaiser E; Pust S; Kroll C; Barth H
Cell Microbiol; 2009 May; 11(5):780-95. PubMed ID: 19159389
[TBL] [Abstract][Full Text] [Related]
30. Clostridium botulinum C2 toxin: binding studies with fluorescence-activated cytometry.
Stiles BG; Blöcker D; Hale ML; Guetthoff MA; Barth H
Toxicon; 2002 Aug; 40(8):1135-140. PubMed ID: 12165316
[TBL] [Abstract][Full Text] [Related]
31. Purification and activity of the Rho ADP-ribosylating binary C2/C3 toxin.
Haug G; Barth H; Aktories K
Methods Enzymol; 2006; 406():117-27. PubMed ID: 16472654
[TBL] [Abstract][Full Text] [Related]
32. Molecular Evolutionary Constraints that Determine the Avirulence State of Clostridium botulinum C2 Toxin.
Prisilla A; Prathiviraj R; Chellapandi P
J Mol Evol; 2017 Apr; 84(4):174-186. PubMed ID: 28382496
[TBL] [Abstract][Full Text] [Related]
33. ADP-ribosylation of actin isoforms by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin.
Mauss S; Chaponnier C; Just I; Aktories K; Gabbiani G
Eur J Biochem; 1990 Nov; 194(1):237-41. PubMed ID: 2253618
[TBL] [Abstract][Full Text] [Related]
34. Internalization of
Nagahama M; Kobayashi K; Ochi S; Takehara M
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33918753
[No Abstract] [Full Text] [Related]
35. Binary actin-ADP-ribosylating toxins and their use as molecular Trojan horses for drug delivery into eukaryotic cells.
Barth H; Stiles BG
Curr Med Chem; 2008; 15(5):459-69. PubMed ID: 18289001
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of C2-toxin inhibition by fluphenazine and related compounds: investigation of their binding kinetics to the C2II-channel using the current noise analysis.
Bachmeyer C; Orlik F; Barth H; Aktories K; Benz R
J Mol Biol; 2003 Oct; 333(3):527-40. PubMed ID: 14556742
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
Gülke I; Pfeifer G; Liese J; Fritz M; Hofmann F; Aktories K; Barth H
Infect Immun; 2001 Oct; 69(10):6004-11. PubMed ID: 11553537
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of the cytopathic action of actin-ADP-ribosylating toxins.
Aktories K; Wegner A
Mol Microbiol; 1992 Oct; 6(20):2905-8. PubMed ID: 1479882
[TBL] [Abstract][Full Text] [Related]
40. EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin.
Schnell L; Mittler AK; Sadi M; Popoff MR; Schwan C; Aktories K; Mattarei A; Azarnia Tehran D; Montecucco C; Barth H
Toxins (Basel); 2016 Apr; 8(4):101. PubMed ID: 27043629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
